Ignite Creation Date:
2024-05-06 @ 9:41 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03042273
Status:
COMPLETED
Last Update Posted:
2020-03-18
First Post:
2017-02-01
Brief Title:
High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection
Sponsor:
Swisse Wellness Pty Ltd
Organization:
Swisse Wellness Pty Ltd
Study Overview
Official Title:
A Randomised Double-blind Placebo Controlled Study to Investigate the Efficacy and Safety of High Strength Cranberry Pacran in Women With Recurrent Urinary Tract Infections Cystitis
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is a Phase 2 multicenter placebo-controlled double-blind parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry 500mg Pacran in preventing UTI cystitis in women with a history of recurrent UTI rUTI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None